SCHEMBL6428433

SCHEMBL6428433

NCCCCCCNC(CCC(N)=O)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.47
GGT1 P19440 1/20 0.46
NOD1 Q9Y239 1/20 0.46
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
KMT2A Q03164 3/20 0.40
ALOX15 P16050 2/20 0.40
BLM P54132 1/20 0.40
PMP22 Q01453 1/20 0.40
GSR P00390 1/20 0.39
CPB2 Q96IY4 2/20 0.39
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
PLG P00747 1/20 0.38
LMNA P02545 1/20 0.38
THRB P10828 1/20 0.38
SLC6A2 P23975 1/20 0.38
RECQL P46063 1/20 0.38
SLC6A3 Q01959 1/20 0.38
SLC6A5 Q9Y345 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27146119 1.00 FOLH1 (0.47) FOLH1GGT1NOD1MAOAMAOB
SCHEMBL9954035 1.00 FOLH1 (0.47) FOLH1GGT1NOD1MAOAMAOB
SCHEMBL6428434 1.00 FOLH1 (0.47) FOLH1GGT1NOD1MAOAMAOB
SCHEMBL5495877 1.00 FOLH1 (0.47) FOLH1GGT1NOD1MAOAMAOB
SCHEMBL30199558 0.98 FOLH1 (0.49) FOLH1GGT1NOD1MAOAMAOB
SCHEMBL8633803 0.93 GGT1 (0.49) FOLH1GGT1NOD1MAOAMAOB
SCHEMBL29448584 0.92 MAOA (0.45) FOLH1GGT1NOD1MAOAMAOB
SCHEMBL16554492 0.88 FOLH1 (0.61) FOLH1GGT1NOD1KMT2AALOX15
Propylamine SCHEMBL28458438 0.88 NOD1 (0.57) GGT1NOD1KMT2ACPB2MEN1
SCHEMBL2254243 0.87 NOD1 (0.46) FOLH1GGT1NOD1KMT2AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050152842-A1 Poly (L-glutamic acid) paramagnetic material complex and use as a biodegradable MRI contrast agent NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-07-14 US disclosed
WO-2005063304-A2 POLY (L-GLUTAMIC ACID) PARAMAGNETIC MATERIAL COMPLEX AND USE AS A BIODEGRADABLE MRI CONTRAST AGENT BOARD OF REGENTS, THE UNIVERSITY OF TEXAS_SYSTEM (US) 2005-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050152842-A1 Poly (L-glutamic acid) paramagnetic material complex and use as a biodegradable MRI contrast agent TFRC, GRIA3, GLUL FOLH1 36/4885GGT1 649/4885NOD1 3711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.